Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | VP, Controller and CAO | July 31, 2018 | August 02, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ZIMMER BIOMET HOLDINGS, INC.
Report date July 31, 2018 · Filed August 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,146 |
Reported balance
After 2018-07-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-07-31 · Exercise / conversion · Acquired 2,670 · Balance 3,146 F1: Includes 138 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between May 1, 2018 and June 29, 2018. |
| Common StockSEC Table I · non-derivative | Direct | 476 |
Reported balance
After 2018-07-31 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2018-07-31 · Sale · Disposed 2,670 · Balance 476 F2: Represents the sale of 2,670 shares in multiple transactions ranging in price from $125.735 to $125.81 per share, resulting in a weighted average sale price of $125.7699. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. |
| Common StockSEC Table I · non-derivative | Direct | 368 |
Reported balance
After 2018-07-31 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2018-07-31 · Sale · Disposed 108 · Balance 368 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $104.01 · Expires 2026-03-21 | Direct | 5,340 |
Reported balance
After 2018-07-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-07-31 · Exercise / conversion · Disposed 2,670 · Balance 5,340 F3: 2,670 options vested on March 21, 2017; 2,670 options vested on March 21, 2018; and the remaining options will vest as to 2,670 options on each of March 21, 2019 and 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 138 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between May 1, 2018 and June 29, 2018.
F2: Represents the sale of 2,670 shares in multiple transactions ranging in price from $125.735 to $125.81 per share, resulting in a weighted average sale price of $125.7699. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
F3: 2,670 options vested on March 21, 2017; 2,670 options vested on March 21, 2018; and the remaining options will vest as to 2,670 options on each of March 21, 2019 and 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2018 Filed Aug 2, 2018 21:12 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,670 | $0.00 Strike: $104.01 | $0.00 |
DisclosureSEC source: 0000911916-18-000147 · edgar.xml · derivative · entry 4 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,340 Underlying: Common Stock · 2,670 shares Expires 2026-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 2,670 options vested on March 21, 2017; 2,670 options vested on March 21, 2018; and the remaining options will vest as to 2,670 options on each of March 21, 2019 and 2020. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 21:12 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 108 | $125.75 | $13,580.46 |
DisclosureSEC source: 0000911916-18-000147 · edgar.xml · nonDerivative · entry 3 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368 Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 21:12 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 2,670 | $125.77 | $335,805.63 |
DisclosureSEC source: 0000911916-18-000147 · edgar.xml · nonDerivative · entry 2 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 476 F2 · price: Represents the sale of 2,670 shares in multiple transactions ranging in price from $125.735 to $125.81 per share, resulting in a weighted average sale price of $125.7699. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 21:12 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,670 | $104.01 | $277,706.70 |
DisclosureSEC source: 0000911916-18-000147 · edgar.xml · nonDerivative · entry 1 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 138 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between May 1, 2018 and June 29, 2018. Read SEC document |
| April 30, 2018 Filed May 1, 2018 20:25 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,213 | $0.00 Strike: $94.34 | $0.00 |
DisclosureSEC source: 0000911916-18-000112 · edgar.xml · derivative · entry 4 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,213 shares Expires 2024-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1,214 options vested on each of March 17, 2016 and 2017; and the remaining 1,213 options vested on March 17, 2018. Read SEC document |
| April 30, 2018 Filed May 1, 2018 20:25 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 117 | $116.32 | $13,609.44 |
DisclosureSEC source: 0000911916-18-000112 · edgar.xml · nonDerivative · entry 3 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338 Read SEC document |
| April 30, 2018 Filed May 1, 2018 20:25 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 1,213 | $116.77 | $141,636.31 |
DisclosureSEC source: 0000911916-18-000112 · edgar.xml · nonDerivative · entry 2 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 455 F2 · price: Represents the sale of 1,213 shares in multiple transactions ranging in price from $116.22 to $117.04 per share, resulting in a weighted average sale price of $116.7653. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| April 30, 2018 Filed May 1, 2018 20:25 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 1,213 | $94.34 | $114,434.42 |
DisclosureSEC source: 0000911916-18-000112 · edgar.xml · nonDerivative · entry 1 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 101 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between July 31, 2017 and January 30, 2018. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:08 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 8,335 | $0.00 Strike: $114.44 | $0.00 |
DisclosureSEC source: 0000911916-18-000065 · edgar.xml · derivative · entry 1 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,335 Underlying: Common Stock · 8,335 shares Expires 2028-03-20 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 10,785 | $0.00 Strike: $119.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000040 · edgar.xml · derivative · entry 1 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,785 Underlying: Common Stock · 10,785 shares Expires 2028-02-20 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,670 | $0.00 Strike: $104.01 | $0.00 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · derivative · entry 14 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,010 Underlying: Common Stock · 2,670 shares Expires 2026-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: 2,670 options vested on March 21, 2017; and the remaining options will vest as to 2,670 options on each of March 21, 2018, 2019 and 2020. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,723 | $0.00 Strike: $113.83 | $0.00 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · derivative · entry 13 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,723 Underlying: Common Stock · 4,723 shares Expires 2025-06-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 2,362 options vested on June 24, 2016; 2,361 options vested on June 24, 2017; and the remaining options will vest as to 2,362 options on June 24, 2018 and as to 2,361 options on June 24, 2019. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,723 | $0.00 Strike: $113.83 | $0.00 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · derivative · entry 12 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,722 Underlying: Common Stock · 4,723 shares Expires 2025-06-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 2,362 options vested on June 24, 2016; 2,361 options vested on June 24, 2017; and the remaining options will vest as to 2,361 options on each of June 24, 2018 and 2019. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,428 | $0.00 Strike: $94.34 | $0.00 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · derivative · entry 11 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,213 Underlying: Common Stock · 2,428 shares Expires 2024-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 1,214 options vested on each of March 17, 2016 and 2017; and the remaining 1,213 of the options are scheduled to vest on March 17, 2018. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,752 | $0.00 Strike: $73.15 | $0.00 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · derivative · entry 10 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,752 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested on March 18, 2017. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 597 | $121.32 | $72,428.04 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 9 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 93 | $121.76 | $11,323.69 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 8 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 951 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 1,200 | $122.38 | $146,855.04 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 7 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,044 F3 · price: Represents the sale of 1,200 shares in multiple transactions ranging in price from $122.16 to $122.52 per share, resulting in a weighted average sale price of $122.3792. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 15,096 | $121.71 | $1,837,326.61 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 6 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,244 F2 · price: Represents the sale of 15,096 shares in multiple transactions ranging in price from $121.15 to $122.14 per share, resulting in a weighted average sale price of $121.7095. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,670 | $104.01 | $277,706.70 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 5 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 4,723 | $113.83 | $537,619.09 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 4 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 4,723 | $113.83 | $537,619.09 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 3 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,428 | $94.34 | $229,057.52 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 2 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 1,752 | $73.15 | $128,158.80 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 1 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 120 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between May 1, 2017 and June 30, 2017. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 20:44 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 8,725 | $0.00 Strike: $121.88 | $0.00 |
DisclosureSEC source: 0000911916-17-000118 · edgar.xml · derivative · entry 1 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,725 Underlying: Common Stock · 8,725 shares Expires 2027-03-21 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 21, 2018. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 19:09 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 878 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000116 · edgar.xml · derivative · entry 3 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 878 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F4 · derivative.exercise_date: The earned RSUs vested on March 17, 2017. F4 · derivative.expiration_date: The earned RSUs vested on March 17, 2017. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 19:09 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 281 | $120.47 | $33,852.07 |
DisclosureSEC source: 0000911916-17-000116 · edgar.xml · nonDerivative · entry 2 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 924 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 19:09 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 878 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000116 · edgar.xml · nonDerivative · entry 1 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,205 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 109 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between October 31, 2016 and January 30, 2017. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 19:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 878 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000052 · edgar.xml · derivative · entry 1 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 878 Underlying: Common Stock · 878 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 878 RSUs. F3 · derivative.exercise_date: Earned RSUs will vest on March 17, 2017. F3 · derivative.expiration_date: Earned RSUs will vest on March 17, 2017. F2 · derivative.underlying_shares: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 878 RSUs. F2 · balance_after: On March 17, 2014, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2014 - 2016. As determined on February 9, 2017, based on the Company's actual performance for 2014 - 2016, the reporting person earned 878 RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.